Ftse Mib
33.694,94
-0,12%
DAX
17.979,68
0,41%
S&P 500
5.107,71
0,86%
NASDAQ
16.112,04
1,71%
Bitcoin
61.709,56
4,38%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Ocuphire Pharma Inc (OCUP) Ocuphire Pharma Inc (OCUP) Notizie

Ocuphire Pharma Inc

OCUP
1,93
0,08 (4,32%)
Ultimo aggiornamento: 16:36:14
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
08/3/202423:20EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
08/3/202414:21EDGAR2Form 8-K - Current report
16/2/202422:31EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
16/2/202422:03EDGAR2Form 8-K - Current report
15/2/202400:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202400:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202400:32EDGAR2Form 3 - Initial statement of beneficial ownership of..
15/2/202400:29EDGAR2Form 3 - Initial statement of beneficial ownership of..
24/1/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
23/1/202400:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202400:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/1/202422:16EDGAR2Form S-8 - Securities to be offered to employees in employee..
10/1/202423:00EDGAR2Form S-3 - Registration statement under Securities Act of..
04/1/202400:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202400:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202400:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202423:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202314:45EDGAR2Form 8-K - Current report
13/11/202323:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202323:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202314:48EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202314:12EDGAR2Form 8-K - Current report
03/11/202314:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202314:22EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/11/202313:44EDGAR2Form 8-K - Current report
01/11/202321:21EDGAR2Form 8-K - Current report
27/9/202314:45EDGAR2Form 8-K - Current report
27/9/202314:00PRNUSViatris and Ocuphire Pharma Announce FDA Approval of..
14/8/202314:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/8/202315:27EDGAR2Form 8-K - Current report
11/8/202314:51EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/8/202317:21EDGAR2Form 8-K - Current report
Apertura: 1,94 Min: 1,86 Max: 1,94
Chiusura: 1,85

La tua Cronologia

NASDAQ
OCUP
Ocuphire Pharma
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network